Development of Imeglimin Electrospun Nanofibers as a Potential Buccal Antidiabetic Therapeutic Approach

• Main Authors: Ali A. Alamer (Author), Nasser B. Alsaleh (Author), Alhassan H. Aodah (Author), Abdullah A. Alshehri (Author), Fahad A. Almughem (Author), Sarah H. Alqahtani (Author), Haya A. Alfassam (Author), Essam A. Tawfik (Author)
• Format: Book
• Published: MDPI AG, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The prevalence of type 2 diabetes (T2D) has been growing worldwide; hence, safe and effective antidiabetics are critically warranted. Recently, imeglimin, a novel tetrahydrotriazene compound, has been approved for use in T2D patients in Japan. It has shown promising glucose-lowering properties by im...